文献速递姑息放疗与转移瘤放疗物理与技术

治疗前影像模态类型对实体瘤骨转移姑息放疗疗效的影响:单中心回顾性分析

Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
PubMed 文献 · Radiat Oncol · 2019-06-07

结果显示105例(80%)为反应者,各影像模态及转移部位、病理性骨折等因素与治疗反应均无显著关联。

要点

  • 治疗前影像模态类型与疼痛性骨转移姑息放疗反应无显著关联。
  • 131例患者中105例(80%)获得疼痛缓解或镇痛药减量。
  • 依据CT图像和临床发现设定放疗野或可避免姑息放疗前额外影像检查。

核心结论

  • 治疗前影像模态类型与实体瘤疼痛性骨转移姑息放疗的治疗反应无显著关系。

主要发现

  • 131例中105例为反应者,反应率80%。
  • 放疗前影像检查:CT 131例、MRI 54例、骨显像56例、18FDG-PET-CT 14例。
  • Welch t检验和卡方检验显示治疗反应与各因素均无显著关联。
  • 纳入影像模态、转移部位和病理性骨折的多重logistic回归分析亦显示各因素与治疗反应无显著关联。

关键数值与推荐

  • 处方剂量为8-50 Gy/1-25次,每次2-8 Gy。
  • 反应定义为患者获得疼痛缓解或减少镇痛药使用。

临床怎么用

  • 依据CT图像和临床发现设定合适放疗野,或可避免疼痛性骨转移姑息放疗前的额外影像检查。

局限性

  • 单中心回顾性设计,样本量有限,18FDG-PET-CT检查者仅14例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Determining the appropriate gross tumor volume is important for irradiation planning in addition to palliative radiation for bone metastases. While irradiation planning is commonly performed using simulation computed tomography (CT), magnetic resonance imaging (MRI), bone scintigraphy, and 18fluorodeoxyglucose-positron emission tomography-CT (18FDG-PET-CT) are more sensitive for detecting bone metastasis and invasion areas. Therefore, this study evaluated whether pretreatment imaging modalities influenced the response to palliative radiation therapy (i.e., the irradiation effect) for painful bone metastases from solid malignant carcinomas. METHODS: Consecutive patients with painful bone metastases treated with palliative radiation between January 2013 and December 2017 at our institution were included. We retrospectively investigated the pretreatment images from the different imaging modalities (CT, MRI, bone scintigraphy, and 18FDG-PET-CT) obtained between 1 month before and the initiation of palliative radiation and determined the primary site of carcinoma, histological type, metastatic lesion type (osteolytic, osteoblastic, or mixed), pathological fracture, and metastatic site (vertebral or not). We then evaluated the relationship between these factors and treatment response. We defined "response" as the condition in which patients achieved pain relief or reduced the use of painkiller medicines. RESULTS: In total, 131 patients (78 men and 53 women) were included; the median age was 66 years (range, 24-89 years). Prescribed doses were 8-50 Gy/1-25 fractions with 2-8 Gy/fraction. Among the 131 patients, 105 were responders (response rate, 80%). The imaging modalities performed before irradiation were CT in 131 patients, MRI in 54, bone scintigraphy in 56, and 18FDG-PET-CT in 14. The Welch t-test and chi-square test showed no significant association between treatment response and each factor. Multiple logistic regression analysis including the imaging modality, metastatic site, and pathological fracture also showed no significant association with each factor. CONCLUSIONS: There was no significant relationship between the type of pretreatment imaging and treatment response for painful bone metastases. Thus, setting the appropriate radiation field according to CT images and clinical findings could help avoiding further image inspection before palliative radiation for painful bone metastases.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wada Y, Anbai A, Kumagai S, et al. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis. Radiat Oncol. 2019. PMID: 31174548. doi:10.1186/s13014-019-1310-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。